ARTICLE
27 January 2026

USPTO Extends PPH Pilot Program To 2029

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
Originally scheduled to end on January 5, 2026, the program has now been extended for an additional three years, until January 5, 2029.
United States Intellectual Property
Randy J. Pummill’s articles from Foley & Lardner are most popular:
  • with readers working within the Retail & Leisure industries
Foley & Lardner are most popular:
  • within Cannabis & Hemp, Coronavirus (COVID-19) and Insolvency/Bankruptcy/Re-Structuring topic(s)

The U.S. Patent and Trademark Office (USPTO) has announced a significant extension of the IP5 Patent Prosecution Highway (PPH) pilot program, continuing cooperation with the European Patent Office (EPO), the Japan Patent Office (JPO), the Ministry of Intellectual Property (MOIP) of the Republic of Korea, and the China National Intellectual Property Administration (CNIPA). Originally scheduled to end on January 5, 2026, the program has now been extended for an additional three years, until January 5, 2029.

The USPTO has implemented stringent requirements that restrict claim amendments in applications pursued through the PPH program, which can limit the practical value of using PPH in the United States. Nevertheless, it is encouraging that U.S. allowances can continue to serve as a basis for accelerated examination in the IP5 offices.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More